UNSPSC 51442210: Gadoteridol

This classification denotes a gadolinium-chelate with the molecular formula C17H29GdN4O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0199MV609F, chemically known as 1,4,7,10-tetraazacyclododecan-1,4,7-triacetic acid, 10-(2-hydroxypropyl)-, gadolinium complex but more generally known as gadoteridol, which bears U.S. National Institutes of Health Compound Identifier 60714. The European Medicines Agency schedules Gadoteridol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07866MIG.

UNSPSC 51442210 Gadoteridol is a Commodity code. Recent state and local solicitations tagged under this pharmaceutical and imaging-agent code show minimal alignment with its nominal scope. The two most recent opportunities involve X-ray equipment maintenance services (Broward County Aviation Department, RFI posted June 25, 2026) and copper sulfate supply (Pasco County, RFQ posted June 3, 2026) — neither of which concerns gadoteridol or related contrast media procurement. State and local procurement records do not show active solicitation activity for gadoteridol itself among the issuing bodies tracked in recent state and local contract databases.

The code shows little relevant recent activity. Both recorded opportunities appear to be miscoded against this Commodity category and reflect procurement needs in equipment servicing and industrial chemical supply rather than pharmaceutical or medical imaging supplies. Absent current solicitations for gadoteridol, contrast media, or related diagnostic pharmaceutical products under this code, this category presents limited pursuit opportunity in the state and local sector at present.